Can I Take Lixisenatide While Pregnant?

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on September 3rd, 2026.

Published on September 3rd, 2026. Updated on September 3rd, 2026.

General 5 min

Key takeaways

  • Lixisenatide is not recommended at any stage of pregnancy due to potential fetal harm.

  • Insulin is the gold standard for managing blood sugar safely throughout pregnancy.

  • Women who discover pregnancy while on lixisenatide should stop it and call their care team promptly.

  • Poorly controlled blood sugar poses serious fetal risks, making a quick medication switch urgent.

  • Preconception planning is the best time to transition off lixisenatide before conception occurs.

Is Lixisenatide Safe to Take During Pregnancy?

The short answer is no, and this matters a lot for you and your baby. Lixisenatide is not recommended during pregnancy at any stage. Regulatory agencies flag it as a potential risk to fetal development, and clinical guidelines advise stopping it before conception or as soon as a pregnancy is confirmed. If you are currently taking it and just found out you are pregnant, that is the first thing to address with your doctor.

Animal studies showed meaningful problems at doses comparable to human use, including fetal growth restriction, skeletal abnormalities, and increased fetal death. Human data is extremely limited because pregnant women are excluded from clinical trials, which means the risk profile is uncertain rather than proven safe.

Why Does Lixisenatide Raise Concerns for a Developing Baby?

Lixisenatide works by activating GLP-1 receptors (specialized proteins that regulate blood sugar and appetite). Those same receptors are present in fetal tissues, raising the concern that the drug may interfere with normal growth signaling during development.

The first trimester is the period of greatest concern. This is when organogenesis (the process of organs forming) occurs, and it is also when many women first realize they are pregnant. The animal data showed dose-dependent effects on fetal weight and bone development, which regulators treat as a serious signal even without confirmed human equivalents.

Key concerns worth knowing:

  • GLP-1 receptor activity in fetal tissue may disrupt normal development signals.
  • Skeletal ossification problems (incomplete bone formation) were seen in animal studies.
  • Fetal weight reduction occurred at exposures relevant to human dosing.
  • No established safe dose exists for any stage of human pregnancy.

What Are the Safer Alternatives for Blood Sugar Control During Pregnancy?

The good news is that well-studied options exist. Your care team can help you transition quickly.

Medication

Pregnancy Safety Rating

Crosses the Placenta?

Recommended in Pregnancy Guidelines?

Lixisenatide

Not recommended, possible fetal harm

Unknown, GLP-1 receptors in fetal tissue

No

Insulin

Most studied, preferred option

No, in clinically meaningful amounts

Yes, first-line choice

Metformin

Acceptable second-line in some cases

Yes, long-term fetal effects still under study

Sometimes, with monitoring

Glyburide

Falling out of favor

Yes

Increasingly discouraged due to neonatal low blood sugar risk

Other GLP-1 agonists (semaglutide, dulaglutide)

Same warnings as lixisenatide

Unknown

No

Insulin is the gold standard. It has decades of safety data, does not cross the placenta in meaningful amounts, and can be adjusted in real time as your body's needs change throughout pregnancy. If you have concerns about injections or dosing, a certified diabetes educator can make the transition much more manageable.

Metformin is used in some pregnancies as a second-line option, though it does cross the placenta and its long-term effects on children are still being studied. It is not the automatic first choice.

What If I Was Already Taking Lixisenatide When I Found Out I Was Pregnant?

This situation is more common than many people realize, and the response is the same: stop lixisenatide promptly and contact your obstetrician and prescribing doctor right away.

A single or brief early exposure is unlikely to guarantee harm, but the absence of reassuring human data means the risk cannot be measured or dismissed. There is no known safe window for continuing it once pregnancy is confirmed.

Two things matter urgently once you stop:

  • Transition to insulin or another approved regimen quickly. Poorly controlled blood sugar itself poses serious risks, including macrosomia (a baby that grows too large), stillbirth, and congenital abnormalities. Replacing lixisenatide is not optional.
  • Do not wait for your next scheduled appointment. Call your care team the same day so the transition plan can begin without delay.

Planning a Pregnancy While on Lixisenatide: What Should You Do First?

Preconception planning is the most effective window to make this transition safely and calmly, without the urgency of an unexpected pregnancy.

Steps worth taking before you try to conceive:

  • Talk to your doctor about stopping lixisenatide at least one to two months before attempting conception. This allows the drug to clear your system and gives you time to establish stable glucose control on a new regimen.
  • Aim for an HbA1c below 6.5% before conception. This target substantially reduces the risk of congenital anomalies and miscarriage linked to high blood sugar in early pregnancy.
  • Start high-dose folic acid. Women with diabetes planning pregnancy are advised to take 5 mg daily (higher than the standard dose), because the risk of neural tube defects is elevated compared to the general population.
  • Check your full medication list. Lixisenatide is now prescribed for weight management as well as diabetes. If you are taking it for obesity rather than blood sugar control, the same pregnancy warnings apply and the same preconception conversation is needed.

Is There Any Reason to Continue Lixisenatide During Pregnancy?

No credible evidence supports continuing lixisenatide during pregnancy for any indication. The appetite-suppression and weight-related benefits of the drug are not appropriate goals during pregnancy, when adequate caloric intake and healthy weight gain are both recommended for fetal development.

Insulin provides superior, more flexible blood sugar control. It can be titrated in real time to match changing insulin resistance throughout pregnancy, and it does not carry the fetal concerns associated with GLP-1 agonists. For anyone weighing whether the benefits of lixisenatide could outweigh the risks in pregnancy, the answer from current evidence and clinical guidelines is a clear no.

Frequently Asked Questions

A brief early exposure is unlikely to guarantee harm, but human safety data is too limited to quantify the risk. Stop the medication immediately and contact your obstetrician and prescribing doctor to transition to a pregnancy-safe blood sugar regimen.

No. All GLP-1 receptor agonists, including semaglutide and dulaglutide, carry the same pregnancy warnings as lixisenatide. None are considered safe alternatives. Insulin is the preferred choice during pregnancy for blood sugar management.

Animal studies showed increased fetal death at relevant doses, but human data is too limited to confirm this risk directly. The concern is real enough that guidelines recommend stopping the drug before or as soon as pregnancy is confirmed.

Insulin is the most studied and recommended option, offering flexible dosing without crossing the placenta meaningfully. Metformin may be used as a second-line option in some cases. Your care team will tailor a regimen based on your glucose targets.

Yes. Guidelines recommend stopping lixisenatide one to two months before trying to conceive, allowing the drug to clear and giving you time to establish stable glucose control on a pregnancy-appropriate regimen like insulin.

The Bottom Line

Lixisenatide carries a clear safety warning in pregnancy, backed by animal data showing fetal growth problems and skeletal abnormalities, and human safety data is too limited to offer reassurance. Safe, well-studied alternatives exist, with insulin being the preferred choice for managing blood sugar throughout pregnancy. If you are pregnant or planning to conceive, switching medications promptly is not optional. Doctronic offers free AI consultations and affordable video visits 24 hours a day to help you start the conversation about a safe transition plan. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get women's health advice

Chat Now